sunitinib
Fluorescent labels and indicators
- An oral anti cancer drug. Works by inhibiting cellular signals by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib is approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) Reference standards of Sunitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => (Z)-N-Ethyl-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]- 2,4-dimethyl-1H-pyrrole-3-carboxamide
[catalogue_number] => PA 19 75520
[category_ids] => ,89,71,80,79,82,78,70,
[chemical_name] =>
[weight] => 327.35
[form] => C18H18FN3O2
[cas] => NA
[pslug] => z-n-ethyl-5-5-fluoro-1-2-dihydro-2-oxo-3h-indol-3-ylidene-methyl-2-4-dimethyl-1h-pyrrole-3-carboxamide-pa1975520
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(Z)-N-Ethyl-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]- 2,4-dimethyl-1H-pyrrole-3-carboxamide
Catalogue No.:PA 19 75520
Molecular Formula : C18H18FN3O2
Molecular Weight : 327.35
stdClass Object
(
[pname] => Sunitinib Amide Impurity
[catalogue_number] => PA 19 75550
[category_ids] => ,78,70,82,89,79,80,
[chemical_name] =>
[weight] => 299.3
[form] => C16H14FN3O2
[cas] => 1186651-51-3
[pslug] => 1186651-51-3-sunitinib-amide-impurity-pa1975550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
